According to Ovid Therapeutics 's latest financial reports the company's current earnings (TTM) are -$52.34 M. In 2022 the company made an earning of -$54.12 M a decrease over its 2021 earnings that were of $0.12 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$52.34 M | -3.29% |
2022 | -$54.12 M | -143.59% |
2021 | $0.12 B | -253.22% |
2020 | -$81.04 M | 34.03% |
2019 | -$60.47 M | 16.32% |
2018 | -$51.98 M | -19.79% |
2017 | -$64.81 M | 189.13% |
2016 | -$22.42 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | -$0.12 B | 111.66% | ๐บ๐ธ USA |